Professional Documents
Culture Documents
Textbook Continuous Renal Replacement Therapy 2Nd Edition John A Kellum Ebook All Chapter PDF
Textbook Continuous Renal Replacement Therapy 2Nd Edition John A Kellum Ebook All Chapter PDF
https://textbookfull.com/product/renal-cancer-contemporary-
management-john-a-libertino/
https://textbookfull.com/product/fast-facts-renal-disorders-2nd-
ed-health-press-singh-a/
https://textbookfull.com/product/music-therapy-a-fieldwork-
primer-2nd-edition-ronald-m-borczon/
https://textbookfull.com/product/the-renal-drug-handbook-the-
ultimate-prescribing-guide-for-renal-practitioners-5th-edition-
caroline-ashley/
2018 - Nelson’s Pediatric Antimicrobial Therapy John S.
Bradley
https://textbookfull.com/product/2018-nelsons-pediatric-
antimicrobial-therapy-john-s-bradley/
https://textbookfull.com/product/2019-nelsons-pediatric-
antimicrobial-therapy-john-d-nelson/
https://textbookfull.com/product/2020-nelsons-pediatric-
antimicrobial-therapy-john-s-bradley/
https://textbookfull.com/product/2021-nelsons-pediatric-
antimicrobial-therapy-27th-edition-john-d-nelson/
https://textbookfull.com/product/brief-dynamic-therapy-2nd-
edition-hanna-levenson/
Continuous Renal
Replacement Therapy
Pittsburgh Critical Care Medicine
Claudio Ronco, MD
Director, Department Nephrology Dialysis and Transplantation
Director of International Renal Research Institute (IRRIV)
San Bortolo Hospital
Vicenza, Italy
1
1
Oxford University Press is a department of the University of Oxford. It furthers
the University’s objective of excellence in research, scholarship, and education
by publishing worldwide.Oxford is a registered trade mark of Oxford University
Press in the UK and certain other countries.
Published in the United States of America by Oxford University Press
198 Madison Avenue, New York, NY 10016, United States of America.
© Oxford University Press 2016
First Edition published in 2010
Second Edition published in 2016
All rights reserved. No part of this publication may be reproduced, stored in
a retrieval system, or transmitted, in any form or by any means, without the
prior permission in writing of Oxford University Press, or as expressly permitted
by law, by license, or under terms agreed with the appropriate reproduction
rights organization. Inquiries concerning reproduction outside the scope of the
above should be sent to the Rights Department, Oxford University Press, at the
address above.
You must not circulate this work in any other form
and you must impose this same condition on any acquirer.
Library of Congress Cataloging-in-Publication Data
Continuous renal replacement therapy/edited by John A. Kellum, Rinaldo Bellomo,
and Claudio Ronco. —2nd edition.
p. ; cm.
Includes bibliographical references and index.
ISBN 978–0–19–022553–7 (alk. paper)
I. Kellum, John A., editor. II. Bellomo, R. (Rinaldo), 1956–, editor.
III. Ronco, C. (Claudio), 1951–, editor.
[DNLM: 1. Acute Kidney Injury—therapy. 2. Hemodialysis Solutions.
3. Kidney—injuries. 4. Renal Replacement Therapy—methods. WJ 342]
RC901.7.H45
617.4′61059—dc23
2015022091
9 8 7 6 5 4 3 2 1
Printed by Webcom, Canada
This material is not intended to be, and should not be considered, a substitute for medical
or other professional advice. Treatment for the conditions described in this material is highly
dependent on the individual circumstances. And, while this material is designed to offer
accurate information with respect to the subject matter covered and to be current as of the
time it was written, research and knowledge about medical and health issues is constantly
evolving and dose schedules for medications are being revised continually, with new side
effects recognized and accounted for regularly. Readers must therefore always check the
product information and clinical procedures with the most up-to-date published product
information and data sheets provided by the manufacturers and the most recent codes
of conduct and safety regulation. The publisher and the authors make no representations
or warranties to readers, express or implied, as to the accuracy or completeness of
this material. Without limiting the foregoing, the publisher and the authors make no
representations or warranties as to the accuracy or efficacy of the drug dosages mentioned
in the material. The authors and the publisher do not accept, and expressly disclaim, any
responsibility for any liability, loss or risk that may be claimed or incurred as a consequence
of the use and/or application of any of the contents of this material.
We dedicate this edition to the nursing professionals who deliver continuous renal
replacement therapy. Without their hard work and dedication, this therapy would
not exist. This volume is also dedicated to patients and their families in the hope
that we make a positive difference in their lives.
Preface
Significant advances have occurred in the care of patients with acute kidney
injury (AKI). Continuous renal replacement therapy (CRRT) has become stan-
dard of care for many critically ill patients with severe acute kidney injury, and
most major medical centers have developed the capability of providing CRRT.
However, many hospitals lack the capacity and many that have it, underuse it.
The goal of this CRRT handbook is to provide a concise but authoritative
guide in the use of CRRT. In a single, slim volume, we cover the basics of CRRT
management as well as some topics related more generally to AKI. The intent
of this book is to provide a quick reference for both novice and experienced
CRRT providers, to enrich existing expertise, and to help all involved in the
care of severe AKI achieve a better understanding of this powerful therapy.
As a result of the tremendous success of the first edition, we have updated
this second edition with new information on machines and biomarkers, and
on a nomenclature that has undergone much-needed standardization dur-
ing the years the first edition was published. We hope that new readers and
vii
those already familiar with the handbook find it useful. Our ultimate goal is to
improve outcomes for patients with AKI through teamwork and education.
John A Kellum
Rinaldo Bellomo
Claudio Ronco
2015
Contents
Contributors╇ xiii
Part 1: Theory
Part 2: Practice
11 Choosing a Renal Replacement Therapy
in Acute Kidney Injury
Jorge Cerdá and Claudio Ronco 93
12 Vascular Access for Continuous Renal
Replacement Therapy
Alexander Zarbock and Kai Singbartl 105
13 The Circuit and the Prescription
Rinaldo Bellomo and Ian Baldwin 111
14 The Membrane: Size and Material
Zhongping Huang, Jeffrey J. Letteri, Claudio Ronco,
and William R. Clark 117
15 Fluids for Continuous Renal Replacement Therapy
Paul M. Palevsky and John A. Kellum 125
16 Alarms and Troubleshooting
Zaccaria Ricci, Ian Baldwin, and Claudio Ronco 131
17 Nonanticoagulation Strategies to Optimize
Circuit Function in RRT
Ian Baldwin 139
18 Anticoagulation
Rinaldo Bellomo and Ian Baldwin 145
19 Regional Citrate Anticoagulation
Nigel Fealy 151
20 Drug Dosing in Continuous Renal Replacement Therapy
Adrian Wong, Sandra L. Kane-Gill, and John A. Kellum 157
xiii
Budapest, Hungary Houston Medical School
Houston, Texas
Jorge Cerdá, MD, FACP, FASN
Clinical Professor of Medicine Francesco Garzotto, PhD
Department of Medicine San Bortolo Hospital
Albany Medical College Department of Nephrology
Albany, New York Dialysis and Transplantation
International Renal Research
Lakhmir S. Chawla, MD Institute of Vicenza
Associate Professor of Medicine Vicenza, Italy
Department of Medicine
Veterans Affairs Medical Center Dehua Gong, MD
Washington, District of Columbia Research Institute of Nephrology
Jinling Hospital
William R. Clark, MD Nanjing University
Senior Medical Director Nanjing, China
Renal Medical Affairs
Baxter Healthcare Corporation
Deerfield, Illinois
Zhongping Huang, PhD Raghavan Murugan,
Contributors
Contributors
Pediatric Cardiac Intensive Care Unit International Renal Research
Department of Pediatric Cardiac Institute of Vicenza
Surgery San Bortolo Hospital
Bambino Gesù Children’s Vicenza, Italy
Hospital, IRCCS Department of Health Sciences
Rome, Italy Section of Anesthesiology
University of Florence
Sara Samoni Florence, Italy
xv
Penn State College of Medicine Resident
Hershey, Pennsylvania University of Pittsburgh School of
Pharmacy
Frederick J.Tasota, RN, MSN Pittsburgh, Pennsylvania
UPMC Presbyterian
Pittsburgh, Pennsylvania Alexander Zarbock, MD
Department of Anaesthesiology
Aditya Uppalapati, MD Intensive Care and Pain Medicine
Department of Medicine University Hospital Münster
Saint Louis University Münster, Germany
Saint Louis, Missouri
Part 1
Theory
Chapter 1
The terms acute kidney injury (AKI) and acute renal failure (ARF) are not syn-
onymous. Although the term renal failure is best reserved for patients who
have lost renal function to the point that life can no longer be sustained with-
out intervention, AKI is used to describe the milder as well as severe forms
of acute renal dysfunction in patients. Although the analogy is imperfect, the
AKI–╉ARF relationship can be thought of as being similar to the relationship
between acute coronary syndrome and ischemic heart failure. AKI is intended
to describe the entire spectrum of disease—╉from being relatively mild to
severe. In contrast, renal failure is defined as renal function inadequate to clear
3
the waste products of metabolism despite the absence of or correction of
hemodynamic or mechanical causes. Clinical manifestations of renal failure
(either acute or chronic) include the following:
• Uremic symptoms (drowsiness, nausea, hiccough, twitching)
• Hyperkalemia
• Hyponatremia
• Metabolic acidosis
Oliguria
Persistent oliguria may be a feature of AKI, but nonoliguric renal failure is not
uncommon. Patients may continue to make urine despite an inadequate glo-
merular filtration. Although prognosis is often better if urine output is main-
tained, use of diuretics to promote urine output does not seem to improve
outcome (and some studies even suggest harm). More important, azotemia
(increased serum creatinine [SCrt]) together with oliguria portends a worse
prognosis than either sign alone.
Classification
The Kidney Disease Improving Global Outcomes (KDIGO) work group
defines AKI as an increase in SCr by 0.3 mg/╉dL or more (≥26.5 mmol/╉L)
Table 1.1 KDIGO criteria for staging severity of AKI
The Critically Ill Patient with AKI
RIFLE (risk, injury, failure, loss, end-stage kidney disease [ESRD]) criteria
developed by the acute dialysis quality initiative and acute kidney injury net-
work (AKIN) criteria developed by an international network of AKI research-
ers were used to define AKI and its severity. They were based on SCrt level
and urine output. Both of these criteria have been well validated in various
patient populations. With increasing severity or stage, AKI was associated with
increasing mortality. These criteria were adopted by the KDIGO in its AKI
clinical practice guideline (Figure 1.1).
ria
or creatinine ≥ 4mg/dL x 24 h or High
Oligu
Failure (acute rise of anuria x 12 h specificity
≥0.5 mg/dL)
Chapter 1
End-stage renal disease
ESRD
Figure 1.1 The RIFLE cCriteria for diagnosis and staging of acute kidney injury AKI—used
to describe three levels of renal impairment (Risk, Injury, Failure) and two clinical outcomes
(Loss and End-stage kidney disease). ARF, acute renal failure; UO, urine output. *An alterna-
tive proposal is to define “risk” to include any increase in serum creatinine of at least
0.3 mg/dL over 48 hours or less, even if less than a 50% increase.
5
Source: Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure: definition, outcome
measures, animal models, fluid therapy and information technology needs: the Second International
Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–
R212. Used with permission.
Clinical features may suggest the cause of AKI and dictate further investigation.
AKI is common in the critically ill, especially in patients with sepsis and other
forms of systemic inflammation (e.g., major surgery, trauma, burns), but other
causes must be considered.
Volume-Responsive AKI
It is estimated that as many as 50% of cases of AKI are “fluid responsive,” and
the first step in managing any case of AKI is to ensure appropriate fluid resus-
citation. However, volume overload is a key factor contributing to the mortal-
ity attributable to AKI, so ongoing fluid administration to nonfluid-responsive
patients is discouraged.
Chapter 1
Sepsis-Induced AKI
Sepsis is a primary cause or contributing factor in more than 50% of cases of
AKI, which includes cases severe enough to require RRT. Patients with sepsis,
including those outside the ICU, develop AKI at rates as high as 40%. Incidence
increases with the severity of sepsis. Sepsis-induced AKI can develop in
patients with normal, decreased, as well as increased renal blood flow. In sep-
sis, the kidney often has a normal histological appearance.
6
Hypotension
Hypotension is an important risk factor for AKI, and many patients with AKI
have sustained at least one episode of hypotension. Treating fluid-responsive
AKI with fluid resuscitation is clearly an important step, but many patients also
require vasoactive therapy (e.g., norepinephrine) to maintain arterial blood
pressure. Despite a common belief among many practitioners, norepineph-
rine does not increase the risk of AKI compared with dopamine, and renal
blood flow actually increases with norepinephrine in animal models of sepsis.
Postoperative AKI
Risk factors of postoperative AKI include hypovolemia, hypotension, major
abdominal surgery, and sepsis. Surgical procedures (particularly gynecological)
may be complicated by damage to the lower urinary tract with an obstruc-
tive nephropathy. Abdominal aortic aneurysm surgery may be associated with
renal arterial disruption. Cardiac surgery may be associated with atheroembo-
lism, hemolysis, and sustained periods of reduced arterial pressure as well as
systemic inflammation.
Other Causes
• Nephrotoxins: May cause renal failure via direct tubular injury, interstitial
nephritis, or renal tubular obstruction. In patients with AKI, all potential
nephrotoxins should be withdrawn.
• Rhabdomyolysis: Suggested by myoglobinuria and increased creatine
Chapter 1
(e.g., urate, oxalate). Release of purines and urate are responsible for ARF
in tumor lysis syndrome.
• Renovascular disorders: Loss of vascular supply may be diagnosed by
renography. Complete loss of arterial supply may occur in abdominal
trauma or aortic disease (particularly dissection). More commonly, the
arterial supply is compromised in part (e.g., renal artery stenosis) and
blood flow is further reduced by hemodynamic instability or locally via
7
drug therapy (e.g., nonsteroidal anti-inflammatory drugs [NSAIDs],
angiotensin-converting enzyme inhibitors). Renal vein obstruction may
be a result of thrombosis or external compression (e.g., raised intra-
abdominal pressure).
• Abdominal compartment syndrome: Suggested by oliguria, a firm abdomen
on physical examination, and increased airway pressures (secondary to
upward pressure on the diaphragms). Diagnosis is likely when sustained,
increased intra-abdominal pressures (bladder pressure measured at end
expiration in the supine position) exceed 25 mmHg. However, abdominal
compartment syndrome may occur with intra-abdominal pressures as low
as 10 mmHg.
Nephrotoxins
Box 1.1 lists some medications that can be nephrotoxic. In addition, aminogly-
cosides, NSAIDs, allopurinol, furosemide, sulfonamides, thiazides, pentami-
dine, amphotericin, organic solvents, Paraquat, herbal medicines, and heavy
metals are also nephrotoxic.
Evaluation of AKI
Evaluation of AKI is based on clinical history, physical examination, labora-
tory results, and assessment of hemodynamics and volume status. Newer
The Critically Ill Patient with AKI
Management of AKI
Identification and correction of reversible causes of AKI is critical. All cases
require careful attention to fluid management and nutritional support.
Chapter 1
there is a urethral disruption) to allow decompression. Ureteric obstruction
requires urinary tract decompression by nephrostomy or stent. A massive
diuresis is common after decompression, so it is important to ensure adequate
circulating volume to prevent secondary AKI.
Hemodynamic Management
9
Fluid-responsive AKI may be reversible in its early stage. However, volume
overload is a key factor contributing to the mortality attributable to AKI, so
ongoing fluid administration to nonfluid-responsive patients is discouraged. In
severe cases, fluid resuscitation may be guided by functional hemodynamic
monitoring, and parameters such as stroke volume variation, pulse pressure
variation, velocity time integral variability, inferior vena cava distensibility
index, and the passive leg raise test can help guide fluid responsiveness. After
assessing fluid status and volume responsiveness, necessary inotrope or vaso-
pressor support should be started to ensure tissue perfusion.
Glomerular Disease
Specific therapy in the form of immunosuppressive drugs may be useful after
diagnosis has been confirmed.
Interstitial Nephritis
Acute interstitial nephritis most often results from drug therapy. However,
other causes include autoimmune disease and infection (e.g., Legionella,
leptospirosis, Streptococcus, cytomegalovirus). Numerous drugs have
been implicated, but the most common ones are as listed in Box 1.1.
Table 1.4 Clinical consequences of AKI
The Critically Ill Patient with AKI
• Secondary hypertension
Pulmonary • Volume overload, decreased • Pulmonary edema, pleural
oncotic pressure effusions
• Infiltration and activation of • Acute lung injury
lung neutrophils by cytokines • Pulmonary hemorrhage
• Uremia
Gastrointestinal • Volume overload • Abdominal compartment
syndrome
10
Chapter 1
help as a temporizing method. However, surgical decompression is the only
definitive therapy and should be undertaken before irreversible end-organ
damage occurs.
11
CRRT forms the mainstay of replacement therapy in critically ill patients who
often cannot tolerate standard hemodialysis because of hemodynamic insta-
bility. Hybrid techniques (discussed in Chapter 25) may be reasonable alterna-
tives in settings in which CRRT cannot be accomplished, but outcome data are
limited. Peritoneal dialysis is not usually sufficient. Mortality in the setting of
ARF in the critically ill is high (40%–60%). Recent studies suggest that sustained
renal failure or incomplete renal recovery is more common than previously
thought (as many as 50% of survivors do not return to baseline renal function
after an episode of ARF).
[In preparation.
[In preparation.
CUMMING (Rev. John, d.d.),—A MESSAGE FROM GOD; or,
Thoughts on Religion for Thinking Men. Fourth Edition,
fcap. cloth, gilt edges, 2s.
—— OUR FATHER; A Manual of Family Prayers for General and
Special Occasions, with Short Prayers for Spare Minutes, and
Passages for Reflection. Sixth Edition. Fcap. cloth, gilt edges,
3s.
—— OCCASIONAL DISCOURSES. New Edition. Two Vols. fcap.
cloth, 8s.
—— PROPHETIC STUDIES; or, Lectures on the Book of Daniel.
Ninth Thousand. Fcap. cloth, full gilt, 9s.
—— PULPIT PSALMODY. Fcap. cloth, 3s. 6d.; roan, 5s.; morocco,
6s. 6d.
—— PSALTER OF THE BLESSED VIRGIN. Written by St.
Bonaventure. Translated from the last French Edition of
1852, and carefully compared with the Latin. 12mo. cloth, 2s.
—— SABBATH EVENING READINGS ON ST. MATTHEW,
complete, with Frontispiece. Fcap. cloth, 5s.
—— ST. MARK. Fcap. cloth, 3s.
—— ST. LUKE. Fcap. cloth, 6s.
—— REVELATION. 2d Edition. Fcap. cloth, 7s. 6d.
—— SALVATION. A Sermon preached before the Queen.
Twentieth Thousand. Sewed, 6d.
—— SIGNS OF THE TIMES. Complete Edition. Fcap. cloth, 3s. 6d.
—— TENT AND THE ALTAR; or, Sketches from Patriarchal Life.
Fcap. cloth, full gilt, 9s.
—— THE WAR AND ITS ISSUES. Sewed, 1s.
—— WELLINGTON. A Lecture. New and Enlarged Edition, with
Valuable Additions. Fcap. cloth, 2s. 6d.
DARTON (Margaret E.),—THE EARTH AND ITS
INHABITANTS. With Frontispiece. Second Edition, crown 8vo.
cloth, 5s.
DECOY (The); or, an Agreeable Method of Teaching Children the
elementary Parts of English Grammar. Sewed, 1s.
DE LA VOYE’S (Marin) NEW CRITICAL FRENCH
PRONOUNCING VOCABULARY, with Exercises on Reading,
and Critical Rules for French Pronunciation. 12mo. bound, 2s.
DESLYON’S FRENCH DIALOGUES, Practical and Familiar,
constructed so as to enable all Persons at once to practise
Conversing in the French Language; with Familiar Letters in
French and English, adapted to the capacities of Youth. New
Edition, 12mo. cloth, 2s. 6d.
—— FRENCH TUTOR; or, Practical Exposition of the best French
Grammarians, with familiar Exercises and Questions on every
Rule, to serve for Examination and Repetition. Third Edition,
12mo. cloth, 4s.
DIALOGUES BETWEEN A POPISH PRIEST AND AN ENGLISH
PROTESTANT, wherein the Principal Points and Arguments of
both Religions are truly Proposed, and fully Examined. By
Matthew Poole. New Edition, with the References revised
and corrected. By the Rev. John Cumming, D.D. 18mo. cloth,
1s. 6d.
DOCTOR’S LITTLE DAUGHTER (The). The Story of a Child’s Life
amidst the Woods and Hills. By Eliza Meteyard, with
numerous Illustrations by Harvey. Fcap. cloth, gilt edges, 7s.
6d.
DOUBLE CLAIM (The), a Tale of Real Life. By Mrs. T. K. Hervey.
With Frontispiece by Weir. Post 8vo. 1s. 6d.
DRAWING-ROOM TABLE-BOOK, With Twenty Illustrations on
Steel. Edited by the Author of “Mary Powell,” 4to. cloth, gilt
edges, 1s. 1d.
EARTH AND ITS INHABITANTS (The), By Margaret E.
Darton. Second Edition, with Frontispiece. Crown 8vo. cloth,
5s.
EDDY’S (DANIEL C.) HEROINES OF THE MISSIONARY
ENTERPRISE; or, Sketches of Prominent Female Missionaries.
With Preface by the Rev. John Cumming, D.D. Second Edition.
Fcap. cloth, gilt edges, 2s. 6d.
EMILIE, THE PEACE-MAKER. By Mrs. Geldart. Frontispiece,
fcap. cloth, 2s. 6d.; gilt edges, 3s.
ENGLISH STORIES OF THE OLDEN TIME. By Maria Hack. A
New Edition. With Vignettes by Harvey.
[In preparation.
[In preparation.
[In preparation.
2. Alfred Campbell.
3. Decision; a Tale.
4. Energy.
5. Fortitude.
6. Humility.
7. Integrity.
8. Moderation.
9. Patience.
10. Reflection.
11. Self-Denial.
12. Young Cadet.
13. Young Pilgrim.
HOFLAND LIBRARY:—
SECOND CLASS, in 18mo.—Price 1s. 6d.
1. Adelaide.
2. Affectionate Brothers.
3. Alicia and her Aunt.
4. Barbados Girl.
5. Blind Farmer and his Children.
6. Clergyman’s Widow.
7. Daughter-in-Law.
8. Elizabeth.
9. Godmother’s Tales.
10. Good Grandmother.
11. Merchant’s Widow.
12. Rich Boys and Poor Boys.
13. The Sisters.
14. Stolen Boy.
15. William and his Uncle Ben.
16. Young Crusoe.
[In preparation.
[In preparation.